MALIGNANT NEOPLASM OF LUNG

Clinical trials for MALIGNANT NEOPLASM OF LUNG explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT NEOPLASM OF LUNG trials appear

Sign up with your email to follow new studies for MALIGNANT NEOPLASM OF LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat lung cancer: testing different doses of promising drug

Disease control Recruiting now

This study is testing two different dosing schedules of the drug adagrasib to see which one works better for people with advanced lung cancer that has a specific genetic change called KRAS G12C. It is for patients whose cancer has continued to grow after trying standard chemother…

Matched conditions: MALIGNANT NEOPLASM OF LUNG

Phase: PHASE2 • Sponsor: Mirati Therapeutics Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

MALIGNANT NEOPLASM OF LUNG

Get alerted when new MALIGNANT NEOPLASM OF LUNG trials appear

New hope for Tough-to-Treat lung cancer: testing different doses of promising drug